Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to help older adults with autism get the recognition they deserve

NCT ID NCT06127472

Knowledge-focused Sponsor: Tilburg University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to improve how healthcare professionals recognize autism in older adults and to test a psychoeducation program for those diagnosed. Around 120 participants aged 55 and older with an autism diagnosis will take part. The goal is to see if better training for doctors and a structured education course can improve quality of life, acceptance, and coping for older adults with autism.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * minimum of 55 years old. * diagnosed with ASD or a probability diagnosis by a multidisciplinary team according to the Dutch multidisciplinary guideline, as confirmed by the DSM-5 interview for ASD (Spek, n.d.), or the Netherlands Interview for Diagnosis of ASD in adults (NIDA; Vuijk, 2023) Exclusion Criteria: * comorbid mental disorder that needs acute treatment and severely interferes with a group treatment (for example psychosis), * a major neurocognitive disorder (for example dementia or acquired brain injury), * substance abuse disorder, that requires detoxification, and/or * an IQ below 70.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism spectrum disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autism spectrum disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dimence

    RECRUITING

    Deventer, Netherlands

  • GGNet Ouderen (Elderly)

    ACTIVE_NOT_RECRUITING

    Apeldoorn, Gelderland, 7334 DZ, Netherlands

  • GGz Breburg PersonaCura

    RECRUITING

    Tilburg, North Brabant, 5025JE, Netherlands

  • GGz Mediant

    ACTIVE_NOT_RECRUITING

    Enschede, Overijssel, 7546 TA, Netherlands

  • GGz NHN Frailty

    ACTIVE_NOT_RECRUITING

    Hoorn, North Holland, 1624 NP, Netherlands

  • GGz WNB Ouderen (Elderly)

    ACTIVE_NOT_RECRUITING

    Halsteren, North Brabant, 4661AA, Netherlands

  • GGzE Nestor

    ACTIVE_NOT_RECRUITING

    Eindhoven, North Brabant, 5623 KW, Netherlands

  • Mondriaan Ouderen (Elderly)

    ACTIVE_NOT_RECRUITING

    Heerlen, Limburg, 6419PJ, Netherlands

  • Reinier van Arkel

    ACTIVE_NOT_RECRUITING

    's-Hertogenbosch, North Brabant, 5223 GZ, Netherlands

  • SeneVita GGZ

    ACTIVE_NOT_RECRUITING

    Eindhoven, North Brabant, 5632 CW, Netherlands

  • Vincent van Gogh Ouderen (Elderly)

    ACTIVE_NOT_RECRUITING

    Venray, Limburg, 5804 AV, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.